LatestIP And Trademarks 30 October 2026
India Design, Patent, Trademark & GI Updates Roundup
A flurry of regulatory and legal updates hits India: UCEED 2027 registration closes tomorrow with a late fee penalty, a court overturns a deemed abandonment of a patent application, the Indian Patent Office rejects TB Alliance's BPaL patent clearing the way for generics, Bombay High Court orders removal of the LEFOXIN BIOX trademark over confusion, CSR‑1 registration rules change under 2025 amendments, Obama ribs Trump over White House redesign, Delhi High Court grants an injunction on the ACFE trademark, a guide outlines business licences for 2026, and Telangana's GI‑tagged Tur Dal makes its first export to Australia.
- UCEED 2027 Registration: Deadline tomorrow; a INR 500 late fee applies after. Read more
- Patent Application Set Aside: Court rejects deemed abandonment, restoring the filing. Read more
- TB Alliance BPaL Patent Rejected: Indian Patent Office declines the patent, opening the market for generic TB drugs. Read more
- LEFOXIN BIOX Trademark Removal: Bombay High Court orders cancellation due to confusion with Lanoxin. Read more
- CSR‑1 Registration Amendments: 2025 changes affect ZCZP ceiling and policy updates. Read more
- Obama vs Trump Design Banter: Obama mocks Trump’s White House makeover; Trump fires back. Read more
- ACFE Trademark Injunction: Delhi High Court blocks fraudulent exam‑coaching brand use. Read more
- Starting a Business in India 2026: Guide to licences, GST, and registration deadlines. Read more
- GI‑Tagged Tur Dal Export: Telangana’s Tur Dal reaches Australia, marking the first GI export shipment. Read more
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.